Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study
2017
150 citations
Journal Article
gold Open Access
Field-Weighted Citation Impact:
9.93
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study | Researchclopedia
Gregory T. Golm
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Samuel S. Engel
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Brett Lauring
·
Merck & Co., Inc., Rahway, NJ, USA (United States)